Request for Covid-19 Impact Assessment of this Report
Epigenetic information transcends that of the genotype alone, provides for an integrated etiologic picture of cardiovascular disease pathogenesis because of the interaction of the epigenome with the environment. Epigenetic biomarkers, which include DNA methylation, histone modifications, and RNA-based mechanisms, are both modifiable and cell-type specific, and are further responsive to the environment, as well as a lucrative option for drug research.
Market Dynamics
Medical usefulness of genetic markers for prediction and prevention of disease related to heart and other muscle cells have been limited. This is an unchartered territory and has attracted the attention of the cardiovascular research community in the field of risk stratification, prevention, and treatment. The field of cardiovascular epigenetics is rapidly growing, although the current enthusiasm about its clinical applications far exceeds available evidence. The study of epigenetics is also appealing as an abstract because processes such as DNA methylation and histone modifications link the genotype and the environment.
Market Segmentation
Epigenetic variation falls into many interconnected categories: DNA methylation, RNA-based mechanisms including microRNAs and non-coding RNAs, and post-translational histone modifications.
Methods used to study Epigenetics:
1. DNA methylation Analysis
--> Bisulfite Conversion : Involves the use of sodium bisulfate conversion to differentially convert unmethylated cytosine residues to uracil.
--> High Resolution Melt Analysis: analysis of a DNA fragment's melt curve following PCR amplification
--> Methylated DNA Immunoprecipitation: MeDIP enables researchers to examine genome-wide changes in DNA methylation patterns
2. Analysis of DNA/Protein Interactions : Preparatory method which involves interaction between proteins (for example, histones) and DNA through the use of antibodies.
3. Chromatin Accessibility and Conformation Assays: Tightly packaged chromatin is also inaccessible to other proteins.
Regional/Geographic Analysis
The market is widely divided demographically, North America, Europe, Asia, and Rest of the World (RoW: Pacific countries, Africa, and Latin America) also grant themselves a dominant market share. The North American market highly dominates the global smart pills market which owes to the favorable reimbursement scenario from the state and other approvals for smart pills technology-based products.
Key players
Some of the major players in the market include Abcam plc. (U.K), Illumina, Inc. (U.S.), Merck & Co. (U.S.), Sigma-Aldrich Corporation (U.S.), Thermo Fisher Scientific, Inc., (U.S.), Active Motif (U.S.), Diagenode Inc. (Belgium) and Zymo Research Corporation (U.S.), etc.
The report contains comprehensive analysis on:
--> Epigenetics Applications Market Segments
--> Epigenetics Applications Market Drivers, Restraints and Opportunities
--> Epigenetics Applications Market Size & Forecast 2016 to 2022
--> Supply & Demand Value Chain
--> Epigenetics Applications Market Current Trends
--> Competition &Major Companies
--> Technology and R&D Status
--> Porters Five Force Analysis
--> Strategic and Critical Success Factor Analysis of Key Players
Regional analysis for Epigenetics Applications Market includes
--> North America
>> US and Canada
--> Latin America
>> Mexico, Brazil, Argentina and Rest of Latin America
--> Western Europe
>> EU5 (Germany, France, Italy, Spain, U.K.)
>> Nordic Countries (Denmark, Finland, Norway, and Sweden)
>> Benelux (Belgium, The Netherlands, and Luxembourg)
>> Rest of Western Europe
--> Eastern Europe
>> Russia
>> Poland
>> Rest of Eastern Europe
--> Asia Pacific
>> China
>> India
>> Japan
>> Australia and New Zealand
>> Rest of Asia Pacific
--> Middle East and Africa
>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
>> South Africa
>> North Africa
>> Rest of Middle East and Africa
This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides in-depth market segmentation that is derived from extensive product mapping exercises, macro-economic factors and other qualitative and quantitative insights. The impact of all such factors are delivered across multiple market segments and geographies.
Report Highlights::
--> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)
--> Consumer and Pricing Analysis
--> Market dynamics of the industry
--> In-depth Market Segmentation
--> Historical and Projected Market Sizing in terms of volume and value
--> Recent market trends and Impact Factors
--> R&D Status and Technology Overview
--> Extensive Industry Structure Coverage
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...